Electromed director reports 3,000-share restricted stock grant on Form 4
Electromed, Inc. reported an insider equity grant to a director.
Rhea-AI Filing Summary
Electromed, Inc. reported an insider equity grant to a director. A board member filed a Form 4 showing an acquisition of 3,000 shares of Electromed common stock on 12/01/2025 at a stated price of $0. These shares are described as restricted stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated under their terms.
After this transaction, the director beneficially owned 38,817 shares of Electromed common stock directly and 1,500 shares indirectly through Liberty Capital, LP. The filing notes that the reporting person disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest in them.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,000 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.
- F2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Electromed (ELMD) disclose in this Form 4?
What role does the reporting person have at Electromed (ELMD)?
Is this Electromed (ELMD) Form 4 filed by one or multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.